eli lilly news glp-1 Lilly's pill hit nearly 1,400 prescriptions in first week FDA Approves Eli Lilly's GLP-1

Among 18,228 adults who had achieved at least 5% weight loss and later stopped treatment, over half regained weight within one year

A diabetes medication that quickly rose to fame for its weight loss effects has experts exploring how it might help treat everything from heart disease to sleep apnea.Ozempic, Wegovy, and Zepbound, which belong to a group of drugs called GLP-1 receptor agonists, are showing promise in helping manage several long-term health problems.

The 2.6 billion manufacturing investment complements the recent US manufacturing expansion for its next potential blockbuster obesity treatment orforglipron.

Data are presented as medians (interquartile ranges) or frequencies (%), and Wilcoxon signed-rank tests and Mann-Whitney U tests were used for paired and nonpaired group comparisons, respectively